Abstract
A Machine Learning Model Based on Tumor and Immune Biomarkers to Predict Undetectable Measurable Residual Disease (MRD) in Transplant-Eligible Multiple Myeloma (MM)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have